Levetiracetam Hexal

Levetiracetam, the active ingredient in Levetiracetam Hexal, is an antiepileptic presented as an injection for intravenous use. It treats partial, generalized tonic‑clonic and myoclonic seizures in patients who need rapid seizure control, including emergency and peri‑operative settings.\n\nGNH India supplies Levetiracetam Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, including tertiary care centres and specialty clinics.

Levetiracetam is an antiepileptic medication indicated for several seizure types.\n\nPartial seizures: reduces the frequency of focal onset seizures.\nGeneralized tonic‑clonic seizures: helps achieve seizure control in primary generalized seizures.\nMyoclonic seizures: decreases the occurrence of myoclonic jerks.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate.\n\nCommon Side Effects:\n- Dizziness\n- Fatigue\n- Somnolence\n- Headache\n- Irritability\n- Nausea\n\nSerious or Rare Side Effects:\n- Severe allergic reactions (anaphylaxis)\n- Stevens‑Johnson syndrome or toxic epidermal necrolysis\n- Blood dyscrasias (e.g., neutropenia)\n- Depression or suicidal thoughts\n- Severe skin rash\n- Hepatic injury

When prescribing Levetiracetam Hexal, clinicians should consider several safety aspects.\n\nRenal impairment: adjust dosing based on creatinine clearance.\nHepatic impairment: monitor liver function tests.\nPregnancy: risk unknown; use only if benefit outweighs potential fetal risk.\nConcomitant CNS depressants: may increase sedation.\nMood changes: monitor for depression or suicidal ideation.\nStore at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam has a relatively low interaction profile, but certain drug combinations require attention.\n\nMajor Interactions (Avoid):\n- Carbamazepine: may reduce levetiracetam plasma levels.\n- Phenytoin: may decrease levetiracetam exposure.\n- Phenobarbital: can lower levetiracetam concentrations.\n\nModerate Interactions (Monitor Closely):\n- CNS depressants (benzodiazepines, opioids): may enhance sedation.\n- Alcohol: can increase central nervous system effects.\n- Valproate: may increase risk of adverse skin reactions.